We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERICS, BRANDS UNLIKELY TO CUT NEW ANTICOMPETITIVE DEALS
GENERICS, BRANDS UNLIKELY TO CUT NEW ANTICOMPETITIVE DEALS
January 13, 2004
The FTC’s recent ruling that Schering-Plough and several generic firms forged anticompetitive pacts in the 1990s sends a message to drugmakers contemplating similar agreements, though some experts say such deals are no longer in favor in the industry.